Background: The implementation of electronic prescribing and medication administration (EPMA) systems is a priority for hospitals and a potential component of antimicrobial stewardship (AMS).
Introduction
Antimicrobial resistance (AMR) is a major threat to public health and a significant resource and cost burden on the UK National Health Service (NHS). 1 The Chief Medical Officer's 2011 report on infections and the rise of AMR called for action to preserve the effectiveness of existing antimicrobials through antimicrobial stewardship (AMS). 1 The 2013 UK Five Year Antimicrobial Resistance Strategy from the Department of Health also highlights AMS as one of seven key areas for action and NHS England has subsequently introduced antimicrobial prescribing reduction goals for English hospitals through the Commissioning for Quality and Innovation programme for 2016/17. In 2012, the UK Department of Health commissioned a study of the potential benefits to staff and patients of greater use of digital and information technology in the NHS and social care. 4 The study report identified four priority actions, one of which was to drive the rollout and use of electronic prescribing (e-prescribing) in secondary care. Implementation of e-prescribing systems in hospitals presents a unique opportunity to improve the quality of antimicrobial prescribing and to facilitate AMS. [5] [6] [7] [8] [9] [10] Evidence for the benefits of AMS functionality within e-prescribing systems comes from published research studies demonstrating positive impact on outcomes including increased guideline adherence 11, 12 and effective initial therapy 13 or reductions in antimicrobial prescribing, 14, 15 resistance, 16, 17 dosing errors, 8 length of hospital or ICU stay 14, 18 and mortality. 12, 13, 19 However, many of these information systems were created on a small scale in individual hospitals or groups of institutions and few reports cover the full potential range of software features that enable AMS. Moreover, there does not appear to be a recognized standard to guide the specification and commissioning of an optimal e-prescribing system that includes the required AMS functionality appropriate for the challenges that health systems currently face worldwide. 20 This report presents results from a cross-sectional survey of UK infection specialist health professionals. The specific objectives of this study were: to identify, using a convenience sample of local infection experts (the nominal group technique), software features within NHS hospital e-prescribing systems that could potentially facilitate AMS; to assign priority to these software features according to the opinions of practising infection specialist healthcare professionals; to identify any differences in priority setting according to professional group, hospital status (teaching or district general) or previous experience of e-prescribing systems; and to communicate research findings to e-prescribing software manufacturers and healthcare policy makers.
Materials and methods
Two focus group meetings of experienced infection health professionals from a local network of hospitals in the south-central region of England were convened in order (i) to identify software features within existing eprescribing and medicines administration (EPMA) systems that facilitate AMS and (ii) to identify additional software features with the potential to facilitate AMS. The focus groups had representation from six infection hospital pharmacists (three with experience of EPMA systems), two consultant medical microbiologists (one with experience of EPMA systems) and one EPMA analyst. The focus group meeting output was a list of software features to be included in a questionnaire for wider circulation among UK infection specialist health professionals. Following the focus groups, two infection pharmacists designed a questionnaire using SurveyMonkey V R software. The questionnaire included 42 questions, which were divided into four domains. The first domain collected respondent demographic data including professional group, experience in a specialist role, hospital setting and EPMA experience. In the remaining three domains, respondents were asked to assign priority to individual software features grouped according to the categories of prescribing alerts/prompts (12 features), active prescription surveillance (11 features) and prescribing trend surveillance (8 features). At the end of each domain, respondents were asked to express their opinion of the anticipated collective impact of the software features from each domain on a number of clinical, microbiological and process outcomes. For the prescribing trend surveillance domain, respondents were asked to prioritize a number of technical aspects of the proposed surveillance reports. Finally, the questionnaire provided a freetext narrative section inviting respondents to suggest additional software features with potential to facilitate AMS, not mentioned earlier in the survey. The questionnaire was piloted in the local region, predominately with infection pharmacists and one medical microbiologist in October 2014. Feedback from the pilot led to the incorporation of one additional category (work efficiency) to the list of process outcomes. A copy of the finalized questionnaire and covering letter to respondents is available as Supplementary data at JAC Online.
Respondents were advised that participation was voluntary and anonymous, that the questionnaire would take 10-12 min to complete and that the results would be disseminated to e-prescribing software manufacturers, policy makers and the clinical infection community. The research team took the decision not to collect personal details of respondent names and employers in order to elicit candid responses; however, respondent internet protocol (IP) addresses were collected, identifying responses from the same healthcare organizations. A hyperlink to the online questionnaire was distributed via health professional networks including the UK Clinical Pharmacy Association, the Royal College of Pathologists, BSAC and PHE. The online questionnaire was closed in July 2015, 7 months from launch. Table 1 presents a glossary of key terms used in the questionnaire that will be referred to throughout this report.
Analysis methods
Questionnaire data were summarized with descriptive statistics and analysed using IBM SPSS v.22 with priority ranking of software features by different groups of respondents compared using the Mann-Whitney U-test. The respondent groups compared were: specialist pharmacists versus medical microbiologists (the number of respondents from other professional groups was too few for statistical analysis); respondents from hospitals with EPMA experience versus those without; and respondents from teaching hospitals versus district general hospitals (DGHs). A P value of <0.05 was considered statistically significant. Finally, the free-text narrative comments were analysed by using a summative approach to qualitative content analysis, grouping responses into common themes according to frequency of reporting. 21 
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Results

Respondent accountability
Responses were received from 164 individuals from 79 unique IP addresses. Twenty-two response sets were removed from the dataset [11 pharmacists, 6 medical microbiologists, 1 infectious diseases (ID) physician, 3 nurses and 1 trainee] due to failure to complete responses to survey questions beyond demographics. Responses from the remaining 142 individuals from 68 unique IP addresses were included in the analysis. Eleven of these 142 did not complete all sections of the questionnaire and missing data were ignored as they comprised <10% of responses.
Respondent demographics
The demographic profile of the 142 respondents included in the analysis is presented in Figure 1 . Infection pharmacists comprised almost half of respondents (48%; 68/142) from 39 IP addresses E-prescribing software features for antimicrobial stewardship JAC and the majority had 5 years' experience in a specialist infection role (47/68). Medical microbiologists represented over one-third of respondents (37%; 53/142) from 35 IP addresses and most had 5 years' experience (48/53). Six ID physicians responded to the survey and a further six respondents were grouped as other healthcare professionals (medical virologist, epidemiologist, junior doctor, infection prevention nurse, surveillance nurse and a consultant in public health).
Fifty-two percent of respondents were from DGHs (71/136 responses) and 45% from teaching hospitals (61/136 responses). Figure 2 illustrates the distribution of experience of EPMA and eprescribing systems amongst the questionnaire respondents. Half of respondents (49%; 68/139) reported experience of EPMA or eprescribing; 59% of 68 infection pharmacists had experience of EPMA in their hospitals compared with 35% of 52 microbiologists. Forty percent (56/139) expected implementation of EPMA within 5 years (25 from teaching hospitals and 29 from DGHs) but 11% (15/139) did not expect EPMA within 5 years (5 from teaching hospitals, 9 from DGHs and one from an unknown setting). Table 2 presents survey response data for priority attributed by respondents to 12 software features of EPMA systems grouped Table 1 . Glossary of key terms used in the survey of opinions of infection specialists on electronic prescribing and antimicrobial stewardship
Prescribing prompt software features
Term Explanation
Prescribing alert/prompt the prescriber will be alerted via a 'pop-up' message-an 'alert or prompt'-e.g. if attempting to prescribe an antimicrobial that is contraindicated because of an allergy or drug interaction Active prescription surveillance active prescription surveillance refers to the application of surveillance data in real time for identification of patients currently prescribed antimicrobial therapy. Software features allow prioritization of patients for intervention by the antimicrobial stewardship team (AST) active prescription surveillance reports would typically include patient name, date of birth, hospital number, inpatient location in the hospital, drug name, drug dose, start date, stop date (if specified), prescriber and responsible senior physician Prescribing trend surveillance prescribing trend surveillance refers to the review of retrospective data relating to antimicrobial prescribing and administration-typically as trends over time. Prescribing trend surveillance allows continuous monitoring of performance for the purposes of quality assurance and for evaluating the impact of stewardship interventions Order sets this software feature allows the prescriber to select an infection (e.g. pneumonia, community acquired, severe) and the system will automatically populate the prescription with the locally pre-defined treatment regimen (single drug or combination of drugs) at standard doses Critical antimicrobial an antimicrobial may be designated 'critical' by a hospital AST according to local priorities, e.g. broad-spectrum antimicrobials such as carbapenems or antimicrobials with a narrow therapeutic range such as colistin. A prescriber may be alerted when prescribing a critical antimicrobial with an appropriate locally defined message containing details of actions required when prescribing Restricted antimicrobial an antimicrobial may be designated 'restricted' by a hospital AST on grounds of financial cost, propensity to predispose to Clostridium difficile infection or local decision to reserve for MDR infections. Prescribing of restricted antimicrobials requires pre-authorization by a medical microbiologist or infectious diseases physician ('restricted antimicrobial authorization') or prescribing is limited by the prescribing software to senior clinicians ('restricted antimicrobial block') Soft stops this software feature allows the prescriber to nominate a date when the antimicrobial prescription should be reviewed with a view to stopping, changing treatment or switching route of administration to oral. After the review date has passed, the drug will remain visible and available to nursing staff to administer but will be prominently highlighted as being past the review (soft stop) date Blood level monitoring order set when a relevant drug is prescribed, the EPMA system will automatically pair the drug prescription with an order for a blood specimen to be taken at an appropriate time post-dose Drug-indication mismatch a mismatch occurs when a prescribed antimicrobial is not appropriate or unauthorized for the recorded indication/provisional diagnosis Days of therapy (DOTs) 1 DOT represents the administration of a single systemic antimicrobial on a given day regardless of the number of doses administered or dosage strength. For example, administration of ceftriaxone as 4 g once daily or as 2 g twice daily for 1 day would both represent 1 DOT. A single patient receiving both vancomycin and ceftazidime during the same day would be recorded as receiving 2 DOTs (1 of vancomycin and 1 of ceftazidime) 47 
Length of therapy (LOT)
LOT refers to antimicrobial course length and is the number of sequential days that a patient receives any systemic antimicrobial drug(s), irrespective of the number of different drugs. 47 A prescription of intravenous piperacillin/tazobactam and vancomycin for 2 days followed by oral co-amoxiclav for 5 days corresponds to a LOT of 7 days Point prevalence point prevalence is the proportion of hospital patients active on the EPMA system that are prescribed any antimicrobial at a specific point in time (e.g. at noon on the first day of each month)
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within the prescribing prompt category. With the exception of restriction features, all prescribing prompt software features were considered essential or high priority by the majority (>50%) of respondents. The features considered essential by >50% of respondents were an allergy checking function and a prompt to prescribers to record the clinical indication for prescribing an antimicrobial.
In comparison with medical microbiologists, specialist pharmacists assigned higher priority to indication prompt (P < 0.001), allergy checker (P ¼ 0.003) and treatment protocols (P ¼ 0.003) ( Table 3 ). Medical microbiologists assigned higher priority to a dose checker for adults (P ¼ 0.023) and an interaction checker (P < 0.05). Respondents from hospitals with EPMA experience assigned higher priority to an indication prompt (P ¼ 0.049), whereas respondents from hospitals without EPMA experience assigned higher priority to restricted antimicrobial block (P ¼ 0.011), dose checker for children (P ¼ 0.024) and blood level monitoring alert (P ¼ 0.033). When responses from teaching hospitals were compared with responses from DGHs, there were no statistically significant differences in opinions of priority for any of the prescribing prompt software features. The majority of respondents considered that both patient safety (60%; 84/140) and ability to deliver AMS (64%; 89/140) were extremely likely to be improved (Figure 3 ).
Active prescription surveillance software features Table 4 presents survey response data for priority attributed by respondents to 11 software features of EPMA systems grouped within the active prescription surveillance category. All but two of the 11 features (daily reports of new or ongoing prescriptions of all antimicrobials) were considered essential or high priority by the majority (>50%) of respondents. Only one feature was considered essential by >50% of respondents: daily report of new prescriptions for critical antimicrobials.
Specialist pharmacists assigned higher priority to a daily report of mismatch between prescribed antimicrobial and associated indication (P ¼ 0.031) and long intravenous (iv)/oral courses (Table 3) . Respondents from hospitals with EPMA experience (in comparison to those without) assigned higher priority to a daily report of newly prescribed critical antimicrobials (P ¼ 0.015) and a daily report of any newly prescribed antimicrobial (P ¼ 0.024). When responses from teaching hospitals were compared with responses from DGHs, there were no statistically significant differences in opinions of priority for any of the active prescription surveillance software features. The majority (>50%) of respondents considered that both patient safety (53%; 71/135) and ability to deliver AMS (60%; 80/134) were extremely likely to be improved (Figure 4) . Two respondents expressed the view that an improvement in outcomes was extremely unlikely: one for reduction in expenditure on drugs and one for reduction in risk of Clostridium difficile.
Prescribing trend surveillance software features
Prescribing trend surveillance reports as a software feature were generally considered by respondents to be of lower priority compared with prescribing prompts and active prescription surveillance, with no trend surveillance software feature rated as essential by >50% of respondents (Table 5) . However, the majority of respondents did consider all of the proposed trend surveillance features to be at least high priority. There were no statistically significant differences in opinions of priority for prescribing trend surveillance software features between specialist pharmacists and medical microbiologists, nor between respondents with or without EPMA experience. Respondents from DGHs assigned higher priority to the report of trends in proportion of stat doses where administration was delayed software feature (P ¼ 0.034) ( Hand et al.
majority of respondents considered that the prescribing trend surveillance group of software features would be likely or extremely likely to have a positive impact on all of the listed clinical, microbiological and process outcomes ( Figure 5 ). More than 90% of respondents anticipated a positive impact on their ability to deliver AMS.
Respondent opinions of selected technical aspects of prescribing trend surveillance reporting are summarized in Table 6 . Respondents expressed equal preference for patient days or patient admissions as an activity denominator. A preference for annual and quarterly reporting intervals rather than more frequent reports was evident. Surveillance reports for the whole hospital and by clinical The two numbers provided relate to the number of respondents from each respondent group. E-prescribing software features for antimicrobial stewardship JAC speciality or hospital department were rated more highly than reports by hospital ward or individual responsible consultant physician. Finally, grouping of surveillance reports of prescribing and administration of individual antimicrobials, by antimicrobial drug class and by locally defined drug groups such as broad-spectrum agents were rated most highly by respondents, with reports grouped by route of administration considered of lesser importance.
Free-text narrative responses
Thirty-five respondents recorded narrative responses when prompted to submit suggestions for additional software features not included in the questionnaire and 69 unique statements were identified and grouped into nine common themes, presented in Table 7 . Eighteen respondents suggested an interface with other electronic systems for previous and current microbiology investigations and results and for drug and clinical information to guide prescribing. There was an apparent demand for flexibility in reporting software to allow reports to be customized locally, but also to generate a standard set of reports for reporting to PHE in accordance with AMS guidance for English Hospitals: 'Start SmartThen Focus'.
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Discussion
This is the first survey of UK infection specialist healthcare professionals evaluating opinions of the potential for e-prescribing software to facilitate AMS. The two largest health professional groups responsible for AMS are represented and the majority of respondents were experienced in a specialist role. We estimate an approximate response rate of 24% of NHS hospital specialist infection pharmacists and 8% of practising UK medical microbiologists. 23, 24 Responses were included from 68 unique IP addresses representing up to 36% (68/188) of NHS hospital trusts/boards if the questionnaire was completed from the employing hospital's IP address. [25] [26] [27] [28] Teaching hospitals are proportionately overrepresented compared with DGHs, but there was a good balance of respondents with experience of EPMA systems and those without. Hand et al.
The prescribing prompt software features ranked as highest priority by respondents were an allergy checker, interaction checker and dose checker, which are already incorporated as standard functionality in a number of existing EPMA systems in NHS hospitals. 29 The response data suggest an unmet need for AMSrelevant features such as recording of indication and 'soft stop' functionality, which are not routinely incorporated into existing EPMA systems. The responses suggest relatively little appetite among UK infection specialists for software features to support restriction of prescribing of selected antimicrobials, possibly reflecting the interspeciality conflict inherent in such policies, resource implications and the lack of longer-term superiority over persuasive interventions. 30 Priorities for active prescription surveillance software features were divided between an emphasis on patient safety (drug-indication mismatch and missed doses) and stewardship (prescriptions for critical antimicrobials and long course lengths). Reports of new or ongoing prescriptions of any antimicrobial were considered lower priority, potentially reflecting the limited resources available to AMS teams to review these prescriptions. 31 Opinions of the expected impact of the proposed prescribing prompt and active prescription surveillance software features on patient outcomes, public health outcomes and resource use outcomes were overwhelmingly positive. It is particularly striking that >90% of respondents considered prescribing prompt software features and active prescription surveillance features either likely or extremely likely to improve patient safety, corroborated by an expectation of improved treatment efficacy and reduced C. difficile infection. An improvement in ability to deliver 
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stewardship and more efficient deployment of stewardship resources was also anticipated. We found that pharmacists were more likely to prioritize a prescribing prompt to record indication, which may reflect the uncertainty faced by hospital pharmacists when validating new prescriptions for antimicrobials (for safety and effectiveness) prior to authorizing dispensing and the requirement to audit antimicrobial prescribing for adherence to local treatment guidelines. 22, 32 Pharmacists also prioritized the treatment protocol software feature, consistent with their preference for daily reports of drug-indication mismatch in contrast to medical microbiologists. We found that medical microbiologists were more likely to prioritize prescribing prompts for dose checking and interaction checking in comparison to pharmacists, perhaps indicating differences in undergraduate teaching and endorsing the value of a multidisciplinary approach to infection management. Respondents from hospitals with experience of EPMA systems ranked the indication prompt feature as relatively more important in comparison to those without, suggesting an unmet need amongst existing software systems.
When technical aspects of surveillance reports were considered, it is of interest that reports by responsible consultant physician were considered of lesser importance than reports by clinical speciality or hospital department. This finding suggests a lack of willingness to employ a 'name-and-shame' approach to stewardship and may represent a preference for promoting a sense of collective responsibility amongst clinician colleagues. Free-text comments identified strong user demand for an interface with the microbiology laboratory software system to support selection of effective therapy and options for de-escalation and to facilitate prompt intervention when patients are prescribed potentially ineffective therapy in cases of drug-bug mismatch.
This cross-sectional survey was designed in accordance with recommended principles of health professional survey design as far as possible within the available resources. 33, 34 However, a shorter questionnaire may have improved the response rate. 33 The exclusion of data relating to address or employer means that we cannot rule out the possibility that multiple responses may have been submitted by the same individuals and it is likely that multiple respondents from the same Trust had an effect on our findings. We were also unable to collect information on non-responders, so the respondent sample is likely to be biased towards more motivated individuals who are engaged with quality improvement and/or information technology. Approximately half of respondents reported experience of EPMA or e-prescribing and this suggests potential bias towards hospitals with such systems when compared with a survey carried out by PHE in 2014, which reported only 17/76 (22%) of respondent hospitals with e-prescribing for at least one inpatient area. 35 The questionnaire did not specifically elicit a description of the existing software features of EPMA systems currently installed in NHS hospitals, but anecdotal evidence from the research team and from professional networks in the UK suggests that software features to support AMS are extremely limited. Some of the software features proposed in this survey may not be technically possible for existing e-prescribing systems and separate data-mining software may be required, particularly for prescribing trend surveillance. Finally, the present questionnaire was primarily distributed by e-mail to members of professional organizations and therefore may not represent the views of nonmembers. The target audience for this survey (consultant medical microbiologists and specialist pharmacists) was deliberate, to focus on individuals most likely to be responsible for stewardship within an NHS hospital organization. However, other healthcare workers also play an important role in AMS at the individual patient level including junior and senior doctors, nurses, non-medical prescribers and ward pharmacists. [36] [37] [38] [39] [40] [41] Inclusion of these professional groups in user-testing at the design stage of EPMA implementation is likely to be critical to the success of the proposed software features. Future surveys focusing on front-line prescribers and medication administrators are critical.
The advent of e-prescribing in NHS hospitals represents a unique new opportunity to engage with healthcare professionals to promote safe, effective and proportionate antimicrobial prescribing and to refresh the AMS message. It must be acknowledged however that with this opportunity also come new threats to patient safety from prescribing and administration errors as well as potential de-skilling of healthcare professionals. [42] [43] [44] The judicious use of educational prompts may facilitate a sustained change in prescribing behaviour, but this must be balanced against the recognized risk of 'alert fatigue' and competing priorities for eprescribing system functionality from other medical and surgical specialities. 45 Successful implementation of the proposed AMS software features into e-prescribing systems will likely be contingent upon a variety of sociotechnical considerations including seamless integration into the prescribing workflow with minimal time penalties for end-users and full compatibility with existing NHS information technology hardware and software. 43, 46 This survey represents the first attempt to canvas opinion of infection specialists in the UK on the potential for e-prescribing software to support AMS. The findings illustrate fundamental principles that are equally relevant to health systems in other countries. The survey results reveal considerable demand for additional software features expressed by the healthcare professionals charged with promoting rational use of antimicrobials and a consensus of anticipated positive impact on patient safety and efficiency outcomes. The survey demonstrates key differences in health professionals' opinions of different healthcare benefits of EPMA and underscores the need for a multidisciplinary approach to the development of EPMA system specifications. We trust this information will prove valuable to software manufacturers currently developing e-prescribing systems when prioritizing software functionality and systems interface development and potentially to healthcare commissioners when drafting e-prescribing system specifications. Finally, we commend this topic to research funders with a view to funding research into the potential benefits and unintended consequences of e-prescribing system functionality designed to support AMS.
